Columbia University Medical Center, New York-Presbyterian and the Life Raft Group have entered into a collaborative effort to advance research to find a cure for GIST using a novel therapeutic approach and patient-driven data. In honor of GIST Awareness Day we have two presentations by Dr. Gary Schwartz and Dr. Andrea Califano about the Innovative Approach […]
Read More
Dr. Anthony Boral, Chief Medical Officer of Blueprint Medicines, provided an update on the clinical development of BLU-285, an investigational medicine being developed for patients with advanced GIST. The presentation included an update on results from Blueprint Medicines’ ongoing Phase 1 clinical trial of BLU-285 in patients with advanced GIST presented at the American Society […]
Read More
The Life Raft Group presented an informative webcast on Fertility, Pregnancy and GIST. Presented on March 30, 2017 Learn about: Impact of cancer treatment on fertility Options to preserve eggs and sperm before treatment Ways to build a family after cancer therapy About the presenter Rosemary O’Neil Semler MA, RN, AOCNS is a Clinical Nurse Specialist […]
Read More
The Life Raft Group presented an informative webcast on Gene Fusions. Presented on February 22, 2017 Learn about: Recently identified gene fusions in GIST Populations they target Current studies that may identify them How they can be used to guide therapeutic decision making. About the presenter Dr. Sicklick is the Associate Professor of Surgery at Moores Cancer […]
Read More
On September 28, 2016, the Life Raft Group was pleased to have Melissa Simpson, Senior Program Manager in the Center for Benefits Access at the National Council on Aging share her knowledge and insight regarding medicare. Ms. Simpson discussed concerns about Medicare including Medicare Part D, supplemental plans and Advocacy. About the presenter Melissa Simpson is a […]
Read MoreOn September 19, 2016 the Life Raft Group was pleased to have Dr. Benjamin D. Humphreys, Chief of the Division of Nephrology at Washington University in St. Louis School of Medicine, share his knowledge and insight regarding kidney disease. Dr. Humphreys reviewed chronic kidney disease and kidney injury as it relates to therapy with both […]
Read MoreOn February 1, 2016, the commercial launch of the generic version of imatinib mesylate (Gleevec), originally for CML (Chronic Myeloid Leukemia), was approved by the FDA and became available for the first time in the United States through Sun Pharmaceuticals. In response to this transition, the LRG provided an educational Webinar to the CML and […]
Read More
In August, the LRG Webcast Series presented “Mutational Analysis of GISTs: How, When and Why.” Dr. Christopher Corless of Oregon Health and Science University (OHSU) presented the hour- long webcast in which he detailed the importance of and the science behind mutational testing. As GIST research has deepened, scientists have learned that instead of being […]
Read More
Please join us for an afternoon of learning about the importance of and the science behind mutational testing with pathologist and GIST specialist, Dr. Christopher Corless of Portland’s Oregon Health and Science University. This presentation will review the role of mutational analysis to subclassify GI Stromal Tumors. This can be valuable in defining prognosis and […]
Read More
A presentation to commemorate the 2nd Annual GIST Awareness Day The Life Raft Group hosted a distinguished panel of experts on GIST Awareness Day to share their knowledge in areas of GIST treatment and management. This educational event provides information for those living with GIST, as well as their care partners and loved ones, about managing their […]
Read More
Dr. Ronald P. DeMatteo discusses surgery and molecular therapy for GIST in this webcast.
Read More
GIST Patient Alice Sulkowski talks about nutrition and healthy living in this informative webcast titled “You are What You Eat: Healthy Living with GIST”.
Read More